Question

Difficulty: MediumMedical Literature and Drug Advertisement Interpretation

A clinical guidelines committee is evaluating the methodology of four recent observational and experimental studies. To correctly appraise the evidence, the committee must identify the primary methodological flaw or bias affecting each study's validity. Match each study methodology description with the specific epidemiological bias it best illustrates.

  • A screening program detects a novel biomarker for asymptomatic pancreatic cancer 6 months earlier than standard imaging. The 3-year survival rate from diagnosis is higher in the screened cohort, but the age-specific mortality rate remains unchanged.Lead-time bias
  • An observational study compares outcomes of a novel oral anticoagulant versus standard therapy. The novel agent is disproportionately prescribed to patients with severe baseline renal impairment, artificially increasing its apparent bleeding risk.Confounding by indication
  • A 5-year prospective study on cognitive behavioral therapy for insomnia includes only the 45% of participants who completed all therapy sessions in its final analysis, excluding all dropouts from the results.Attrition bias
  • A retrospective case-control study investigates the link between congenital malformations and maternal herbal tea consumption. Mothers of affected infants are surveyed 5 years post-delivery about their first-trimester dietary habits.Recall bias

Answer

Study 1 matches Lead-time bias; Study 2 matches Confounding by indication; Study 3 matches Attrition bias; Study 4 matches Recall bias.
Each study design flaw accurately aligns with a specific epidemiological bias. Early detection increasing apparent survival time without changing overall mortality is the hallmark of lead-time bias. Disproportionate prescription of a treatment to a sicker subgroup, which independently affects the outcome, is confounding by indication. Excluding study dropouts from the final analysis creates attrition bias (a form of selection bias). Finally, surveying patients years after a traumatic event (such as having an infant with anomalies) reliably introduces recall bias compared to a healthy control group.

Step-by-Step Solution

1
Analyze the first study description for survival rate inflation without a true mortality benefit.
Identified as Lead-time bias.
The apparent increase in survival is purely due to earlier detection, not delayed death.
2
Analyze the second study description for baseline differences driving treatment selection.
Identified as Confounding by indication.
The indication for the drug (or provider preference for sicker patients) is independently linked to the adverse outcome (bleeding risk).
3
Analyze the third study description for the effect of excluding study dropouts.
Identified as Attrition bias.
Loss to follow-up and exclusion of non-completers skews the final population, violating intention-to-treat principles.
4
Analyze the fourth study description for potential memory discrepancies between the two groups.
Identified as Recall bias.
Having a child with anomalies prompts stronger, often disproportionate, maternal recollection of potential exposures compared to mothers of healthy children.

Key Concept

Identifying and categorizing epidemiological biases based on study design and participant follow-up flaws.
Estimated Time:1m 30s
Rate this question